Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel compound versus ustekinumab in a humanized mouse model of psoriasis
NL-OMON37700Not yet recruiting
- Sponsor
- TNO
- Start
- May 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of ustekinumab in psoriasis and plaque psoriasis (2 arms), sponsored by TNO. Primary endpoints: Effect on psoriatic process in transplanted biopsies and Epidermal thickness. Planned start May 2012; status: not yet recruiting.
02
Drugs
ustekinumab
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on NL-OMON37700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37700.